Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accomplishments in 2008 in the management of localized pancreatic cancer.

Literature DB >> 20011563

Accomplishments in 2008 in the management of localized pancreatic cancer.

Eileen M O'Reilly¹, Manfred P Lutz, Peter Neuhaus.

Abstract

Overview of the DiseaseIncidenceRisk FactorsPrognostic or Predictive FactorsCurrent General Therapy StandardsAccomplishments During the YearTherapyBiomarkersBasic ScienceWhat Needs to Be Done?Applications of the AccomplishmentsControversies and DisagreementsFuture DirectionsComments on ResearchObstacles to Progress.

Entities: Disease

Year: 2009 PMID： 20011563 PMCID： PMC2791394

Source DB: PubMed Journal: Gastrointest Cancer Res ISSN： 1934-7820

30 in total

1. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Authors: Ross A Abrams; Andrew M Lowy; Eileen M O'Reilly; Robert A Wolff; Vincent J Picozzi; Peter W T Pisters
Journal: Ann Surg Oncol Date: 2009-04-24 Impact factor: 5.344

2. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.

Authors: Ching-Wei D Tzeng; Andrey Frolov; Natalya Frolova; Nirag C Jhala; J Harrison Howard; Selwyn M Vickers; Donald J Buchsbaum; Martin J Heslin; J Pablo Arnoletti
Journal: J Surg Res Date: 2007-11 Impact factor: 2.192

3. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors: Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal: J Clin Oncol Date: 2009-03-09 Impact factor: 44.544

4. Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy.

Authors: T Niwa; M Ueno; S Ohkawa; T Yoshida; T Doiuchi; K Ito; T Inoue
Journal: Br J Radiol Date: 2009-01 Impact factor: 3.039

5. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer.

Authors: Karl Y Bilimoria; Mark S Talamonti; Stephen F Sener; Malcolm M Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko; David J Bentrem
Journal: J Am Coll Surg Date: 2008-06-30 Impact factor: 6.113

6. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

Authors: Michele M Corsini; Robert C Miller; Michael G Haddock; John H Donohue; Michael B Farnell; David M Nagorney; Aminah Jatoi; Robert R McWilliams; George P Kim; Sumita Bhatia; Matthew J Iott; Leonard L Gunderson
Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544

7. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

Authors: Joseph M Herman; Michael J Swartz; Charles C Hsu; Jordan Winter; Timothy M Pawlik; Elizabeth Sugar; Ray Robinson; Daniel A Laheru; Elizabeth Jaffee; Ralph H Hruban; Kurtis A Campbell; Christopher L Wolfgang; Fariba Asrari; Ross Donehower; Manuel Hidalgo; Luis A Diaz; Charles Yeo; John L Cameron; Richard D Schulick; Ross Abrams
Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544

8. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Authors: Douglas B Evans; Gauri R Varadhachary; Christopher H Crane; Charlotte C Sun; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Huamin Wang; Karen R Cleary; Gregg A Staerkel; Chusilp Charnsangavej; Elizabeth A Lano; Linus Ho; Renato Lenzi; James L Abbruzzese; Robert A Wolff
Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544

9. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.

Authors: Adam C Berger; Miguel Garcia; John P Hoffman; William F Regine; Ross A Abrams; Howard Safran; Andre Konski; Alan B Benson; John MacDonald; Christopher G Willett
Journal: J Clin Oncol Date: 2008-11-24 Impact factor: 44.544

10. A prospective study of physical activity and the risk of pancreatic cancer among women (United States).

Authors: Brook A Calton; Rachael Z Stolzenberg-Solomon; Steven C Moore; Arthur Schatzkin; Catherine Schairer; Demetrius Albanes; Michael F Leitzmann
Journal: BMC Cancer Date: 2008-02-28 Impact factor: 4.430

1 in total

1. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis.

Authors: Tewfik Hamidi; Hana Algül; Carla Eliana Cano; Maria José Sandi; Maria Inés Molejon; Marc Riemann; Ezequiel Luis Calvo; Gwen Lomberk; Jean-Charles Dagorn; Falk Weih; Raul Urrutia; Roland Michael Schmid; Juan Lucio Iovanna
Journal: J Clin Invest Date: 2012-05-08 Impact factor: 14.808

1 in total